Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in Humans
- 15 January 1996
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (2), 266-271
- https://doi.org/10.1161/01.cir.93.2.266
Abstract
Background Endothelium-derived nitric oxide (NO) may be an important mediator of vascular resistance in the pulmonary circulation. We tested the hypotheses that in conscious adults the endothelium, through NO production, is important in maintaining basal pulmonary vascular resistance and that it can increase NO production further in response to receptor-mediated stimulation, leading to further vasodilation. Methods and Results Pulmonary arterial resistance vessel function was studied within the distribution of a segmental lower lobe pulmonary artery in eight conscious adults 37 to 76 years old who were undergoing cardiac catheterization. Segmental blood flow was determined with use of a Doppler-tip guide wire and quantitative angiography. Drugs were administered locally within the segmental artery through an infusion catheter. NG-Monomethyl-l-arginine (L-NMMA) was used as a specific inhibitor of NO production, whereas acetylcholine (ACh) was used to test receptor-mediated vasodilation. To demonstrate that vasodilation to ACh was NO dependent, ACh response was tested alone, in the presence of L-NMMA, and in the presence of a control constrictor phenylephrine. Basal pulmonary vascular resistance was NO dependent because L-NMMA infusion resulted in a dose-dependent decrease in local flow velocity (P<.005), with flow decreasing 33% at the highest dose of L-NMMA. ACh infusion resulted in a dose-dependent increase in flow velocity (P=.001). The ACh response was at least in part NO dependent because it was diminished by the presence of L-NMMA (P<.05). The effect of L-NMMA on the ACh response was not due to nonspecific preconstriction because L-NMMA diminished the ACh response significantly more than did the endothelium-independent constrictor phenylephrine (P<.05) despite comparable preconstriction. Conclusions In healthy conscious adults, (1) normal basal pulmonary resistance is maintained in part by continuous local production of NO and (2) the local NO production is responsive to receptor-mediated stimulation, leading to further vasodilation, and can be tested with ACh.Keywords
This publication has 26 references indexed in Scilit:
- Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wireAmerican Heart Journal, 1993
- Endothelium-dependent pulmonary artery responses in chronic heart failure: Influence of pulmonary hypertensionJournal of the American College of Cardiology, 1993
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- NG-monomethyl-l-arginine causes nitric oxide synthesis in isolated arterial rings: Trouble in paradiseBiochemical and Biophysical Research Communications, 1992
- Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat.Journal of Clinical Investigation, 1991
- Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivoActa Physiologica Scandinavica, 1990
- Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factorBiochemical and Biophysical Research Communications, 1989
- A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.Journal of Clinical Investigation, 1988
- INFLUENCE OF ACETYLCHOLINE ON THE PULMONARY ARTERIAL PRESSUREHeart, 1957
- THE EFFECT OF ACETYLCHOLINE ON PULMONARY VASCULAR RESISTANCE AND LEFT ATRIAL PRESSURE IN MITRAL STENOSISHeart, 1957